Millennium Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Millennium Management’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47,916	Closed	-$16K	–	6984
2023 Q1	$16K	Buy	+47,916	New	+$19.5K	﹤0.01%	5934
2022 Q4	–	Sell	-38,068	Closed	-$16K	–	7317
2022 Q3	$16K	Buy	+38,068	New	+$15.1K	﹤0.01%	6529
2022 Q1	–	Sell	-21,880	Closed	-$28K	–	7806
2021 Q4	$28K	Sell	21,880 -46,743	-68%	-$74.6K	﹤0.01%	6580
2021 Q3	$141K	Sell	68,623 -254,741	-79%	-$451K	﹤0.01%	6277
2021 Q2	$511K	Buy	323,364 +306,652	+1,835%	+$568K	﹤0.01%	5291
2021 Q1	$37K	Buy	+16,712	New	+$44K	﹤0.01%	5793
2020 Q2	–	Sell	-388,656	Closed	-$909K	–	4745
2020 Q1	$909K	Buy	388,656 +44,599	+13%	+$125K	﹤0.01%	2523
2019 Q4	$757K	Sell	344,057 -111,037	-24%	-$219K	﹤0.01%	3140
2019 Q3	$837K	Sell	455,094 -699,662	-61%	-$1.22M	﹤0.01%	2956
2019 Q2	$1.67M	Buy	+1,154,756	New	+$2.02M	﹤0.01%	2516
2014 Q4	–	Sell	-74,554	Closed	-$324K	–	4364
2014 Q3	$324K	Buy	74,554 +22,681	+44%	+$111K	﹤0.01%	3045
2014 Q2	$257K	Buy	+51,873	New	+$267K	﹤0.01%	2962

Other funds holding NYMX

Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's NYMX Position: Q2 2023 in Review

Millennium Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2023, closing a stake of 47,916 shares — an estimated $16K sold.

Millennium Management first reported a position in NYMX in Q2 2014 and held it in 12 quarters. The position peaked at $1.67M in Q2 2019. 36 funds tracked by Wall St. Rank hold NYMX as of Q2 2023.

Millennium Management reported no remaining Nymox Pharmaceutical Corp position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 47,916 Nymox Pharmaceutical Corp shares in Q2 2023, an estimated $16K.
Millennium Management first reported a position in Nymox Pharmaceutical Corp in Q2 2014 and held it in 12 quarters.
Millennium Management's Nymox Pharmaceutical Corp position peaked at $1.67M in Q2 2019.
36 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.